BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34816972)

  • 21. Neuropsychological Outcomes at 19 Years of Age Following Extremely Preterm Birth.
    O'Reilly H; Johnson S; Ni Y; Wolke D; Marlow N
    Pediatrics; 2020 Feb; 145(2):. PubMed ID: 31924688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for post-COVID cognitive dysfunctions: the impact of psychosocial vulnerability.
    Picascia M; Cerami C; Panzavolta A; Bernini S; Calculli A; Regalbuto S; Pisani A
    Neurol Sci; 2023 Aug; 44(8):2635-2642. PubMed ID: 37349527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 associated cognitive impairment: A systematic review.
    Tavares-Júnior JWL; de Souza ACC; Borges JWP; Oliveira DN; Siqueira-Neto JI; Sobreira-Neto MA; Braga-Neto P
    Cortex; 2022 Jul; 152():77-97. PubMed ID: 35537236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facial emotion recognition in patients with subjective cognitive decline and mild cognitive impairment.
    Pietschnig J; Aigner-Wöber R; Reischenböck N; Kryspin-Exner I; Moser D; Klug S; Auff E; Dal-Bianco P; Pusswald G; Lehrner J
    Int Psychogeriatr; 2016 Mar; 28(3):477-85. PubMed ID: 26377027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cognitive alterations in patients recovered from COVID-19 treated in Cardiopulmonary Rehabilitation].
    Domínguez-Paredes AL; Varela-Tapia CL; Dorado-Arias V; Salazar-Núñez E; Martínez-Barro D
    Rev Med Inst Mex Seguro Soc; 2023 Nov; 61(6):796-801. PubMed ID: 37995338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive impairment in people with previous COVID-19 infection: A scoping review.
    Bertuccelli M; Ciringione L; Rubega M; Bisiacchi P; Masiero S; Del Felice A
    Cortex; 2022 Sep; 154():212-230. PubMed ID: 35780756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychological deficits in patients with cognitive complaints after COVID-19.
    García-Sánchez C; Calabria M; Grunden N; Pons C; Arroyo JA; Gómez-Anson B; Lleó A; Alcolea D; Belvís R; Morollón N; Mur I; Pomar V; Domingo P
    Brain Behav; 2022 Mar; 12(3):e2508. PubMed ID: 35137561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What's going on following acute covid-19? Clinical characteristics of patients in an out-patient rehabilitation program.
    Albu S; Zozaya NR; Murillo N; García-Molina A; Chacón CAF; Kumru H
    NeuroRehabilitation; 2021; 48(4):469-480. PubMed ID: 33998551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Episodic long-term memory in post-infectious SARS-CoV-2 patients.
    Aiello EN; Fiabane E; Manera MR; Radici A; Grossi F; Ottonello M; Vassallo C; Pain D; Pistarini C
    Neurol Sci; 2022 Feb; 43(2):785-788. PubMed ID: 34791568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection Part 1: Cognitive functioning.
    Whiteside DM; Basso MR; Naini SM; Porter J; Holker E; Waldron EJ; Melnik TE; Niskanen N; Taylor SE
    Clin Neuropsychol; 2022 May; 36(4):806-828. PubMed ID: 35130818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Greater executive dysfunction in patients post-COVID-19 compared to those not infected.
    Becker JH; Lin JJ; Twumasi A; Goswami R; Carnavali F; Stone K; Rivera-Mindt M; Kale MS; Naasan G; Festa JR; Wisnivesky JP
    Brain Behav Immun; 2023 Nov; 114():111-117. PubMed ID: 37586567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment.
    Vanderlind WM; Rabinovitz BB; Miao IY; Oberlin LE; Bueno-Castellano C; Fridman C; Jaywant A; Kanellopoulos D
    Curr Opin Psychiatry; 2021 Jul; 34(4):420-433. PubMed ID: 34016818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive impairment and neuropsychiatric symptoms among individuals with history of symptomatic SARS-CoV-2 infection: a retrospective longitudinal study.
    Sousa NMF; Maranhão ACPF; Braga LW
    Dement Neuropsychol; 2024; 18():e20230053. PubMed ID: 38425703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex.
    Hugon J; Msika EF; Queneau M; Farid K; Paquet C
    J Neurol; 2022 Jan; 269(1):44-46. PubMed ID: 34143277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19.
    Jaywant A; Vanderlind WM; Alexopoulos GS; Fridman CB; Perlis RH; Gunning FM
    Neuropsychopharmacology; 2021 Dec; 46(13):2235-2240. PubMed ID: 33589778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life.
    Poletti S; Palladini M; Mazza MG; De Lorenzo R; ; Furlan R; Ciceri F; Rovere-Querini P; Benedetti F
    Eur Arch Psychiatry Clin Neurosci; 2022 Aug; 272(5):773-782. PubMed ID: 34698871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of COVID-19 on cognition and mood after hospitalization and at 2-month follow-up.
    Peskar M; Šimunič B; Šlosar L; Pišot S; Teraž K; Gasparini M; Pišot R; Marusic U
    Front Psychol; 2023; 14():1141809. PubMed ID: 37303911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive assessment in patients with myotonic dystrophy type 2.
    Peric S; Gunjic I; Delic N; Stojiljkovic Tamas O; Salak-Djokic B; Pesovic J; Petrovic Djordjevic I; Ivanovic V; Savic-Pavicevic D; Meola G; Rakocevic-Stojanovic V
    Neuromuscul Disord; 2022 Sep; 32(9):743-748. PubMed ID: 35879188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive impairment in young adults with post COVID-19 syndrome.
    Herrera E; Pérez-Sánchez MDC; San Miguel-Abella R; Barrenechea A; Blanco C; Solares L; González L; Iza C; Castro I; Nicolás E; Sierra D; Suárez P; González-Nosti M
    Sci Rep; 2023 Apr; 13(1):6378. PubMed ID: 37076533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
    Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
    Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.